Is TRT Safe for Your Heart? What the TRAVERSE Trial Found

You felt low for years. Flat energy, soft workouts, a libido that quietly faded, a mood that ran darker than it used to. Bloodwork finally pointed at low testosterone, and treatment made sense. Then someone in your life heard the word testosterone and asked the question that stops a lot of men cold. Won't that wreck your heart?

It is a fair worry. For more than a decade, testosterone therapy carried a cloud over it, fed by a couple of older studies and a warning label that scared men off something that might have helped them. The good news is that we now have real answers, from the largest trial ever built to test exactly this question. This post walks through what that trial found, why the FDA changed its position in 2025, and what actually keeps testosterone safe for your heart.

Where the Heart Scare Came From

For years, testosterone got handed out with almost no follow-up, and then blamed when things went sideways. Around 2013 and 2014, a few studies suggested men on testosterone might have a higher risk of heart problems. The headlines ran hard with it. The FDA responded by adding a warning to testosterone labels about possible cardiovascular risk.

Here is the part that rarely made the news. Those studies had real problems. Some looked backward at messy medical records instead of running a controlled trial. One was stopped early and involved a small group of older, very sick men. None of them were built from the ground up to answer the heart question cleanly. So you had a serious warning resting on shaky ground, and a generation of men either avoided treatment they needed or quietly worried every time they gave themselves a shot.

Doctors knew the evidence was thin. What was missing was a large, properly designed trial built for one purpose: to find out whether testosterone, given to men who actually need it, raises heart risk. That trial is now done.

What the TRAVERSE Trial Was Built to Answer

The trial is called TRAVERSE. It was the kind of study the field had been waiting on for years, and it was designed specifically to settle the heart safety question.

TRAVERSE enrolled 5,246 men. These were not young, healthy guys looking for an edge. They were middle-aged and older men with low testosterone confirmed on bloodwork, plus symptoms, and they either already had heart disease or carried a high risk for it. In other words, the trial loaded the deck with exactly the men you would expect to be most vulnerable if testosterone were truly hard on the heart.

Half the men received testosterone, applied as a gel to keep levels steady. The other half received a placebo. Then researchers followed them and counted the events that matter most: heart attacks, strokes, and deaths from heart causes. This is the structure that makes a study trustworthy. Two matched groups, one real treatment, one fake, and nobody picking who got what.

What the TRAVERSE Trial Found

The main result was the one men have been hoping to hear. In men with low testosterone treated to a normal range, testosterone therapy did not raise the risk of heart attack, stroke, or cardiovascular death compared to placebo.

Sit with that for a second. The largest trial ever run on this question, stacked with men already at high heart risk, did not find that testosterone harmed their hearts. The fear that drove a decade of hesitation did not hold up when it was finally tested the right way.

The trial was honest about a few signals worth knowing. Men on testosterone had slightly more cases of irregular heartbeat (atrial fibrillation), a few more episodes of a clot in the leg, and a small uptick in acute kidney injury. These are reasons to be monitored, not reasons to be afraid. They are the kind of thing a provider watches for on a schedule, the same way they watch your other markers. None of them changed the headline result on heart attacks and strokes.

So the answer to the big question is reassuring, with an honest footnote. Testosterone used appropriately, in men who need it, did not increase the major heart risks people feared.

Why the FDA Removed Its Warning in 2025

Evidence is supposed to change minds, and in this case it did. After TRAVERSE and the larger body of research around it, the FDA reviewed the data and, in 2025, removed the broad cardiovascular warning that had sat on testosterone products for years. The labeling now reflects what the trial actually showed rather than the older, weaker studies.

That is a meaningful shift. A warning that kept men away from treatment, and made the men already on it nervous, was walked back because the science no longer supported it. If you put off testosterone partly because of that warning, the ground it stood on has changed.

One word keeps doing the heavy lifting in all of this: appropriately. The trial studied men with genuinely low levels, treated back into a normal range, in a controlled setting. That is replacement therapy. It is not the same as a man chasing supraphysiologic levels with no testing, no plan, and no one watching the markers that matter. The safety record belongs to testosterone done right.

What Actually Keeps Testosterone Safe

A clean trial result does not mean you can ignore your labs. It means the therapy is safe when it is run the way the trial ran it: real diagnosis, real dosing, real monitoring. Most of the trouble men run into traces back to a dose that climbs too high or a body left unchecked. Both are catchable. Here is what a provider should be tracking.

• Total and free testosterone, to confirm your levels are actually back in a healthy range and not overshooting it
• Hematocrit and a full blood count, because testosterone tells your body to make more red blood cells, and blood that runs too thick raises clot risk
• Estradiol, since testosterone converts to estrogen, and an unwatched climb brings on moodiness, water retention, and tender breast tissue
• Blood pressure and a lipid panel, because heart health is part of the same picture, not a separate one
• PSA and a prostate check appropriate to your age

Notice the theme. Hematocrit, estradiol, blood pressure. The markers that keep testosterone safe are the same markers a quick-script clinic skips. The therapy earns its safety record from monitoring, and monitoring is the part that gets dropped when a man is handed a vial and sent home. We build this kind of tracking into our advanced testing, so nothing important goes unwatched between visits.

How We Approach Testosterone and Heart Health

Men usually come to us after the fast version let them down. A level that was technically normal. A fifteen minute visit. A prescription with no plan and no follow-up. That is the version that earned testosterone its bad name, because it skipped the exact steps that make it safe.

We run it the other way. Onboarding starts with an 80+ biomarker blood panel and a full body composition scan, so your provider sees your whole picture, including your heart markers, before changing anything. Then you get a 60-minute provider consultation to walk through every result together and build a dose around your biology, not a template. From there, follow-up labs guide every adjustment. If hematocrit drifts up or estradiol climbs, it gets handled early, before it turns into a symptom.

This is also why we look past testosterone alone. Low energy and a struggling heart often share roots in metabolism, inflammation, and lifestyle, which is the whole point of functional medicine. If your real concern is your cardiovascular picture, our work on heart health goes deeper than a single hormone. And if your symptoms are wider than testosterone, our men's health program looks at the full range, from fatigue to erectile dysfunction, instead of treating one number in isolation. You can read more about the therapy itself on our testosterone replacement therapy page.

Frequently Asked Questions

Does TRT cause heart attacks or strokes?

The TRAVERSE trial, which enrolled 5,246 men with low testosterone and existing or high heart risk, did not find that testosterone therapy raised the risk of heart attack, stroke, or cardiovascular death compared to placebo. The word that matters is appropriately. The safety applies to men who genuinely need treatment, dosed back into a normal range and monitored over time.

Why did the FDA used to warn about testosterone and the heart?

A few older studies around 2013 and 2014 suggested a possible heart risk, and the FDA added a warning in response. Those studies had real weaknesses, including small or sick groups and designs that looked backward at records rather than running a controlled trial. Once stronger evidence came in, the FDA reviewed it and removed the broad cardiovascular warning in 2025.

If I already have heart disease, can I still consider TRT?

Many of the men in the TRAVERSE trial already had heart disease or were at high risk for it, which is what makes the result so useful. That said, this is a decision to make with a provider who reviews your full picture first, including your blood pressure, lipids, and other markers, and who keeps watching them. It is not a self-prescribe situation.

What heart-related markers should be monitored on TRT?

At a minimum, your provider should track hematocrit and a full blood count to keep your blood from getting too thick, plus blood pressure and a lipid panel. Estradiol and your testosterone levels round out the picture, since a dose running too high is what tends to push markers in the wrong direction. Regular bloodwork is what catches drift before it becomes a problem.

Is the heart risk the same if I buy testosterone online without monitoring?

No, and this is the important caveat. The reassuring trial results come from testosterone used appropriately: real diagnosis, careful dosing, and ongoing labs. Buying it without testing or follow-up means no one is watching hematocrit, estradiol, or your heart markers, which is exactly the setup that invites the problems the therapy is supposed to avoid.

The Heart Question Has an Answer Now

For a long time, men had to weigh feeling like themselves again against a vague fear about their hearts. That trade-off was built on weak evidence, and the strongest study we have has largely cleared it up. Testosterone, given to men who need it and monitored the right way, did not raise the heart risks people feared, and the FDA's labeling now reflects that.

What is left is the part that was always the real work: the right diagnosis, the right dose, and a provider who keeps watching your numbers instead of handing you a vial and disappearing. If you have been running on empty, or you put off testosterone because of a warning that no longer holds, we can help you sort it out with testing behind it. Start Feeling Like Yourself Again with a plan built around your labs and your heart, not a guess.